Cargando…
Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2
[Image: see text] The receptor binding domain (RBD) of SARS-CoV-2 is the primary target of neutralizing antibodies. We have previously reported the design and characterization of a mammalian cell expressed RBD derivative, mRBD1-3.2, that has higher thermal stability and greatly enhanced immunogenici...
Autores principales: | Kanjo, Kawkab, Chattopadhyay, Gopinath, Malladi, Sameer Kumar, Singh, Randhir, Jayatheertha, Sowrabha, Varadarajan, Raghavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942533/ https://www.ncbi.nlm.nih.gov/pubmed/36790910 http://dx.doi.org/10.1021/acs.jpcb.2c07262 |
Ejemplares similares
-
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
por: Malladi, Sameer Kumar, et al.
Publicado: (2020) -
Immunogenicity and Protective Efficacy of a Highly
Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain
Derivative
por: Malladi, Sameer Kumar, et al.
Publicado: (2021) -
Rapid Identification of Secondary Structure and Binding Site Residues in an Intrinsically Disordered Protein Segment
por: Chandra, Soumyanetra, et al.
Publicado: (2021) -
Identification of stabilizing point mutations through mutagenesis of destabilized protein libraries
por: Ahmed, Shahbaz, et al.
Publicado: (2022) -
A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern
por: Ahmed, Shahbaz, et al.
Publicado: (2021)